Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Underwriting Considerations Think about what the risk and complicating issues arise is if obesity is untreated, and perhaps ask the question of where the applicant would fall in terms of risk classification had it not been for the medication along with potential benefits of using the medication
Employers and health plans should evaluate GLP-1s within the context of total cost of care and implement strategies that balance access, outcomes, and sustainability
As the WL achieved with the novel obesity pharmacotherapies approaches that of bariatric surgery, we will need to assess whether long-term complications observed after bariatric surgery such as increased risk of osteoporosis, fractures, macro- and micronutrient deficiencies as well as self-harm behaviours will also be present with pharmacotherapy [112, 113]
)
Switching providers every 30 days resets your progress and wastes money on repeated intake fees
